Press/Media
- 125 - 150 out of 862 results
Search results
-
Collegium Pharmaceutical climbs 19% in 2024, outperforming Medical/Drugs sector
13/09/24
1 item of Media coverage
Press/Media
-
Biohaven Pharmaceutical Holding sinks 16% in 2024, underperforming 81% of the market
13/09/24
1 item of Media coverage
Press/Media
-
-
Monthly: Biohaven Pharmaceutical Holding (BHVN: $39.40) rises on high volatility in August 2024
3/09/24
2 items of Media coverage
Press/Media
-
-
Collegium Pharmaceutical surges 63% in past year, outperforming 87% of the market
3/09/24
2 items of Media coverage
Press/Media
-
Monthly: Collegium Pharmaceutical (COLL: $38.46) falls on below average volume in August 2024
30/08/24
1 item of Media coverage
Press/Media
-
Monthly: Biohaven Pharmaceutical Holding (BHVN: $39.40) rises on high volatility in August 2024
30/08/24
1 item of Media coverage
Press/Media
-
New faculty, programs and initiatives to highlight Emory’s academic year
29/08/24
1 item of Media coverage
Press/Media
-
Pediatric Obesity ECHO provides expert medical care for kids in rural communities
26/08/24
1 item of Media coverage
Press/Media
-
-
DYER'S LASTING LEGACY AFTER 30 YEARS AT OSU-CHS
16/08/24 → 17/08/24
2 items of Media coverage
Press/Media
-
-
Oklahoma students are headed back to school. An OSU psychiatrist has tips for supporting them
15/08/24
1 item of Media coverage
Press/Media
-
-
Pediatric Obesity ECHO Provides Expert Medical Care for Kids in Rural Communities
14/08/24
1 item of Media coverage
Press/Media
-
PEDIATRIC OBESITY ECHO PROVIDES EXPERT MEDICAL CARE FOR KIDS IN RURAL COMMUNITIES
13/08/24
1 item of Media coverage
Press/Media
-
Pediatric Obesity ECHO provides expert medical care for kids in rural communities
13/08/24
2 items of Media coverage
Press/Media
-
Collegium Pharmaceutical climbs 15% in 2024, outperforming Medical/Drugs sector
9/08/24
1 item of Media coverage
Press/Media
-
-
New Clinical Trial Research Study Findings Recently Were Reported by Researchers at Oklahoma State University (Assessment of Rehabilitation Journal Requirements for the Use of Reporting Guidelines and Clinical Trial Registration)
Vassar, M., Smith, C., Brewer Nees, D. & Hughes, G.
6/08/24
1 item of Media coverage
Press/Media
-
Collegium Pharmaceutical jumps 25% in 2024, outperforming 81% of the market
5/08/24
1 item of Media coverage
Press/Media
-
Collegium Pharmaceutical surges 69% in past year, outperforming 92% of the market
5/08/24
1 item of Media coverage
Press/Media